{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T13:47:17Z","timestamp":1776692837330,"version":"3.51.2"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-025-06894-6","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T07:19:05Z","timestamp":1766042345000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Lessons learned from Canadian family physicians deprescribing medications in older adults \u2013 a five-year retrospective review of medico-legal cases"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2238-811X","authenticated-orcid":false,"given":"Jeffrey D","family":"Smith","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4526-7054","authenticated-orcid":false,"given":"Cheryl A","family":"Sadowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8488-6018","authenticated-orcid":false,"given":"Justin Y","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0839-4633","authenticated-orcid":false,"given":"Genevieve M","family":"Casey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine E","family":"Larivi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PJ","family":"Finestone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7633-5630","authenticated-orcid":false,"given":"Gary E","family":"Garber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"6894_CR1","doi-asserted-by":"publisher","unstructured":"Statistics Canada. Tables 17-10-0005-01: population estimates on July 1, by age and gender. 2024 Sep 25. https:\/\/doi.org\/10.25318\/1710000501-eng. Modified 2025; Accessed 2025 Aug 18.","DOI":"10.25318\/1710000501-eng"},{"issue":"1","key":"6894_CR2","doi-asserted-by":"publisher","first-page":"e0312873","DOI":"10.1371\/journal.pone.0312873","volume":"20","author":"K Nicholson","year":"2025","unstructured":"Nicholson K, Salerno J, Borhan S, Cossette B, Guenter D, Vanstone M, et al. The co-occurrence of Multimorbidity and polypharmacy among middle-aged and older adults in canada: A cross-sectional study using the Canadian longitudinal study on aging (CLSA) and the Canadian primary care Sentinel surveillance network (CPCSSN). PLoS ONE. 2025;20(1):e0312873.","journal-title":"PLoS ONE"},{"key":"6894_CR3","unstructured":"Canadian Institute for Health Information. Drug use among seniors in Canada. 2022 Oct 20. https:\/\/www.cihi.ca\/en\/drug-use-among-seniors-in-canada.\u00a0\u00a0Accessed 2025 Aug 18."},{"issue":"7","key":"6894_CR4","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1111\/jgs.18372","volume":"71","author":"2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel","year":"2023","unstructured":"2023 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. American geriatrics society 2023 updated AGS beers Criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2023;71(7):2052\u201381.","journal-title":"J Am Geriatr Soc"},{"key":"6894_CR5","unstructured":"Canadian Institute for Health Information. Changes in drug prescribing to seniors in Canada. 2022 Oct 20. https:\/\/www.cihi.ca\/en\/changes-in-drug-prescribing-to-seniors-in-canada. Accessed 2025 Aug 18."},{"issue":"3","key":"6894_CR6","first-page":"1","volume":"18","author":"Institute for Safe Medication Practices (ISMP)","year":"2018","unstructured":"Institute for Safe Medication Practices (ISMP). Canada. Deprescribing: managing medications to reduce polypharmacy. ISMP Can Saf Bull. 2018;18(3):1\u20136.","journal-title":"ISMP Can Saf Bull"},{"issue":"4","key":"6894_CR7","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/ijpp\/riad025","volume":"31","author":"H Omuya","year":"2023","unstructured":"Omuya H, Nickel C, Wilson P, Chewning B. A systematic review of randomised-controlled trials on deprescribing outcomes in older adults with polypharmacy. Int J Pharm Pract. 2023;31(4):349\u201368.","journal-title":"Int J Pharm Pract"},{"key":"6894_CR8","doi-asserted-by":"crossref","unstructured":"Hoel RW, Giddings Connolly RM, Takahashi PY. Polypharmacy management in older patients. Mayo Clin Proc. 2021;96(1):242\u201356.","DOI":"10.1016\/j.mayocp.2020.06.012"},{"key":"6894_CR9","unstructured":"Health Canada. A path to improving medication appropriateness in Canada. 2024 Jul 26. https:\/\/www.canada.ca\/en\/health-canada\/corporate\/about-health-canada\/activities-responsibilities\/canadian-drug-agency-transition-office\/path-improving-medication-appropriateness-canada.html. Modified 2024; Accessed 2025 Aug 18."},{"issue":"11","key":"6894_CR10","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.1007\/s11606-020-06089-2","volume":"35","author":"HE Bloomfield","year":"2020","unstructured":"Bloomfield HE, Greer N, Linsky AM, Bolduc J, Naidl T, Vardeny O, et al. Deprescribing for community-dwelling older adults: a systematic review and meta-analysis. J Gen Intern Med. 2020;35(11):3323\u201332.","journal-title":"J Gen Intern Med"},{"issue":"8","key":"6894_CR11","doi-asserted-by":"publisher","first-page":"e2326910","DOI":"10.1001\/jamanetworkopen.2023.26910","volume":"6","author":"F Tian","year":"2023","unstructured":"Tian F, Chen Z, Zeng Y, Feng Q, Chen X. Prevalence of use of potentially inappropriate medications among older adults worldwide: a systematic review and meta-analysis. JAMA Netw Open. 2023;6(8):e2326910.","journal-title":"JAMA Netw Open"},{"issue":"2","key":"6894_CR12","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","volume":"99","author":"A Van Zee","year":"2009","unstructured":"Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health. 2009;99(2):221\u20137.","journal-title":"Am J Public Health"},{"issue":"11","key":"6894_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1177\/2042098618795770","volume":"9","author":"D Okeowo","year":"2018","unstructured":"Okeowo D, Patterson A, Boyd C, Reeve E, Gnjidic D, Todd A. Clinical practice guidelines for older people with Multimorbidity and life-limiting illness: what are the implications for deprescribing? Ther Adv Drug Saf. 2018;9(11):619\u201330.","journal-title":"Ther Adv Drug Saf"},{"issue":"5","key":"6894_CR14","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s40266-023-01016-6","volume":"40","author":"PJ Monette","year":"2023","unstructured":"Monette PJ, Schwartz AW. Optimizing medications with the geriatrics 5Ms: an age-friendly approach. Drugs Aging. 2023;40(5):391\u20136.","journal-title":"Drugs Aging"},{"key":"6894_CR15","unstructured":"Deprescribing.org. What is deprescribing? 2025. https:\/\/deprescribing.org\/what-is-deprescribing\/. Accessed 2025 Aug 18."},{"issue":"6","key":"6894_CR16","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254\u201368.","journal-title":"Br J Clin Pharmacol"},{"key":"6894_CR17","unstructured":"Suraweera W, Weerasooriya J, Fernando N. A simple approach to text analysis using SAS functions. In: Proceedings of the SAS Global Forum 2018 Conference [Internet]. SAS Global Forum: 2018 Apr 8\u201310; Denver, Colorado, United States of America. Cary, North Carolina: SAS Institute Inc; 2018. https:\/\/support.sas.com\/resources\/papers\/proceedings18\/. Accessed 2025 Aug 15."},{"issue":"7","key":"6894_CR18","doi-asserted-by":"publisher","first-page":"e19064","DOI":"10.2196\/19064","volume":"23","author":"I Hendrickx","year":"2021","unstructured":"Hendrickx I, Voets T, van Dyk P, Kool RB. Using text mining techniques to identify health care providers with patient safety problems: exploratory study. J Med Internet Res. 2021;23(7):e19064.","journal-title":"J Med Internet Res"},{"issue":"4","key":"6894_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/jhrm.21348","volume":"38","author":"A McCleery","year":"2019","unstructured":"McCleery A, Devenny K, Ogilby C, Dunn C, Steen A, Whyte E, et al. Using medicolegal data to support safe medical care: A contributing factor coding framework. J Healthc Risk Manag. 2019;38(4):11\u20138.","journal-title":"J Healthc Risk Manag"},{"key":"6894_CR20","first-page":"27","volume-title":"The SAGE handbook of interview research: the complexity of the craft","author":"JF Gubrium","year":"2012","unstructured":"Gubrium JF, Holstein JA. Narrative practice and the transformation of interview subjectivity. In: Gubrium JF, Holstein JA, Marvasti AB, McKinney KD, editors. The SAGE handbook of interview research: the complexity of the craft. 2nd ed. Thousand Oaks, California: SAGE; 2012. pp. 27\u201343.","edition":"2"},{"issue":"1","key":"6894_CR21","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12875-023-02147-w","volume":"24","author":"A McDougall","year":"2023","unstructured":"McDougall A, Fortier JH, Zhang C, Ehrat C, Best K, Blois H, et al. Family physicians\u2019 questions about the COVID-19 pandemic: a content analysis of 2,272 helpline calls. BMC Prim Care. 2023;24(1):192.","journal-title":"BMC Prim Care"},{"issue":"3","key":"6894_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/medu.14374","volume":"55","author":"A McDougall","year":"2021","unstructured":"McDougall A, Zaslow J, Zhang C, Yang Q, Nuth J, Tsai E, et al. The medico-legal helpline: A content analysis of postgraduate medical trainee advice calls. Med Educ. 2021;55(3):387\u201393.","journal-title":"Med Educ"},{"key":"6894_CR23","doi-asserted-by":"publisher","first-page":"e074892","DOI":"10.1136\/bmj-2023-074892","volume":"385","author":"A Hung","year":"2024","unstructured":"Hung A, Kim YH, Pavon JM. Deprescribing in older adults with polypharmacy. BMJ. 2024;385:e074892.","journal-title":"BMJ"},{"issue":"1","key":"6894_CR24","first-page":"28","volume":"34","author":"AV Langford","year":"2024","unstructured":"Langford AV, Warriach I, McEvoy AM, Karaim E, Chand S, Turner JP, et al. What do clinical practice guidelines say about deprescribing? A scoping review. BMJ Qual Saf. 2024;34(1):28\u201339.","journal-title":"BMJ Qual Saf"},{"issue":"5","key":"6894_CR25","first-page":"339","volume":"64","author":"K Pottie","year":"2018","unstructured":"Pottie K, Thompson W, Davies S, Grenier J, Sadowski CA, Welch V, et al. Deprescribing benzodiazepine receptor agonists: Evidence-based clinical practice guideline. Can Fam Physician. 2018;64(5):339\u201351.","journal-title":"Can Fam Physician"},{"issue":"1","key":"6894_CR26","first-page":"17","volume":"64","author":"LM Bjerre","year":"2018","unstructured":"Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline. Can Fam Physician. 2018;64(1):17\u201327.","journal-title":"Can Fam Physician"},{"issue":"8","key":"6894_CR27","first-page":"584","volume":"64","author":"A Crawley","year":"2018","unstructured":"Crawley A, Murphy L, Regier L, McKee N. Tapering opioids using motivational interviewing. Can Fam Physician. 2018;64(8):584\u20137.","journal-title":"Can Fam Physician"},{"key":"6894_CR28","unstructured":"Rx Files. Tapering opioids: how to explore and pursue the option for patients who stand to benefit. Spring 2018 Newsletter. https:\/\/www.rxfiles.ca\/rxfiles\/uploads\/documents\/Opioid-Tapering-Newsletter-Compilation.pdf. Accessed 2025 Aug 15."},{"key":"6894_CR29","unstructured":"Ministry of Health (Saskatchewan). Multidisciplinary medication review guide. Government of Saskatchewan, Saskatchewan, Canada. 2013. https:\/\/medstopper.com\/files\/MultidisciplinaryMedicationReviewGuideFinal2013(2).doc. Accessed 2025 Aug 15."},{"issue":"1","key":"6894_CR30","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41514-023-00132-2","volume":"10","author":"M Robinson","year":"2024","unstructured":"Robinson M, Mokrzecki S, Mallett AJ. Attitudes and barriers towards deprescribing in older patients experiencing polypharmacy: a narrative review. NPJ Aging. 2024;10(1):6.","journal-title":"NPJ Aging"},{"issue":"2","key":"6894_CR31","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1093\/ijpp\/riad001","volume":"31","author":"DA Okeowo","year":"2023","unstructured":"Okeowo DA, Zaidi STR, Fylan B, Alldred DP. Barriers and facilitators of implementing proactive deprescribing within primary care: a systematic review. Int J Pharm Pract. 2023;31(2):126\u201352.","journal-title":"Int J Pharm Pract"},{"issue":"6","key":"6894_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.sapharm.2018.08.013","volume":"15","author":"W Thompson","year":"2019","unstructured":"Thompson W, Reeve E, Moriarty F, Maclure M, Turner J, Steinman MA, et al. Deprescribing: future directions for research. Res Social Adm Pharm. 2019;15(6):801\u20135.","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"6894_CR33","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1177\/17151635221114114","volume":"155","author":"M Desai","year":"2022","unstructured":"Desai M, Park T. Deprescribing practices in canada: A scoping review. Can Pharm J (Ott). 2022;155(5):249\u201357.","journal-title":"Can Pharm J (Ott)"},{"issue":"2","key":"6894_CR34","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/bmjqs-2020-010881","volume":"30","author":"AV Langford","year":"2021","unstructured":"Langford AV, Gnjidic D, Lin CC, Bero L, Penm J, Blyth FM, et al. Challenges of opioid deprescribing and factors to be considered in the development of opioid deprescribing guidelines: a qualitative analysis. BMJ Qual Saf. 2021;30(2):133\u201340.","journal-title":"BMJ Qual Saf"},{"key":"6894_CR35","doi-asserted-by":"publisher","first-page":"111204","DOI":"10.1016\/j.jclinepi.2023.10.020","volume":"165","author":"AV Langford","year":"2024","unstructured":"Langford AV, Bero L, Lin CC, Blyth FM, Doctor JN, Holliday S, et al. Context matters: using an evidence to decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care. J Clin Epidemiol. 2024;165:111204.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"6894_CR36","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1186\/s12913-024-11457-3","volume":"24","author":"M Mostafapour","year":"2024","unstructured":"Mostafapour M, Smith JD, Fortier JH, Garber GE. Beyond medical errors: exploring the interpersonal dynamics in physician-patient relationships linked to medico-legal complaints. BMC Health Serv Res. 2024;24(1):1003.","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"6894_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.7861\/futurehosp.3-2-114","volume":"3","author":"A Coulter","year":"2016","unstructured":"Coulter A, Oldham J. Person-centred care: what is it and how do we get there? Future Hosp J. 2016;3(2):114\u20136.","journal-title":"Future Hosp J"},{"key":"6894_CR38","unstructured":"Health Innovation Network. What is person-centred care and why is it important? London: Health Innovation Network; 2016. https:\/\/healthinnovationnetwork.com\/report\/what-is-person-centered-care-and-why-is-it-important\/. Accessed 2025 Oct 14."},{"key":"6894_CR39","unstructured":"Canadian Medical Protective Association. Patient-centred communication, Ottawa, ON: Canadian Medical Protective Association; 2021. Accessed 2025 Oct 14. https:\/\/www.cmpa-acpm.ca\/en\/education-events\/good-practices\/physician-patient\/patient-centred-communication"},{"issue":"1","key":"6894_CR40","doi-asserted-by":"publisher","first-page":"mzad114","DOI":"10.1093\/intqhc\/mzad114","volume":"36","author":"Y Wang","year":"2024","unstructured":"Wang Y, Ram SS, Scahill S. Risk identification and prediction of complaints and misconduct against health practitioners: a scoping review. Int J Qual Health Care. 2024;36(1):mzad114.","journal-title":"Int J Qual Health Care"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06894-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06894-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06894-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:44:03Z","timestamp":1769168643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-025-06894-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6894"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06894-6","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research ethics approval was obtained from the Advarra (Canada) Institutional Review Board (PRO00020829) in compliance with Canada\u2019s Tri-Council Policy Statement on the Ethical Conduct for Research Involving Humans (TCPS 2). The Board waived the need for participant consent for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CB, CZ, GEG, KEL, PJF, and JDS are employees of CMPA, a not-for-profit mutual defense organization for Canadian physicians, at the time of this study. CAS is a member of the CADeN Research Committee, Health care professional committee, and Indigenous Working Group. JYL is co-Chair of the CADeN Research Committee and co-Chair of the Canadian Geriatrics Society Deprescribing and Medication Optimization Special Interest Group. No other competing interests were declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}